News Conference News SCAI 2019 Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics Yael L. Maxwell May 21, 2019
News Conference News CRT 2019 SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients Yael L. Maxwell March 14, 2019
News Conference News CRT 2019 Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy L.A. McKeown March 06, 2019
News Conference News ISET 2019 PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later Caitlin E. Cox February 07, 2019
News Conference News VIVA 2018 No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy L.A. McKeown November 13, 2018
News Conference News ISET 2018 WISE LE Data Build the Case for Embolic Protection in Lower-Extremity Atherectomy Caitlin E. Cox February 13, 2018
News Conference News VIVA 2017 Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients L.A. McKeown September 11, 2017
News Conference News ISET 2017 Routine Screening of ABI to Identify PAD: Despite Guidelines, One Expert Asks Why Not? Caitlin E. Cox February 06, 2017
News Conference News VIVA 2016 Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions L.A. McKeown September 22, 2016
News Conference News VIVA 2016 Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear L.A. McKeown September 21, 2016
News Conference News ACC 2016 Choosing Radial Over Femoral: Single-Center Study Tackles Questions of When and Why Yael L. Maxwell April 06, 2016
News Conference News ISET 2016 Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired Michael O'Riordan February 10, 2016
News Conference News EuroPCR 2013 Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices Jason Kahn May 22, 2013